Abstract
Objectives
In order to identify oral candidiasis patients being at risk of carrying potentially drug-resistant Candida, the aim of the study was to detect local, systemic, demographic, and health-related factors influencing (I) yeast spectrum composition and (II) antifungal administration frequency. Additionally, the aim was to investigate (III) species shift occurrence.
Materials and methods
Data from 798 patients (496 females, 302 males; mean age 59.7) with oral candidiasis diagnosed based on positive clinical and microbial findings (species identification and CFU count) between 2006 and 2011 were retrospectively analyzed using Pearson’s chi2 test and regression analysis.
Results
Among 958 isolates, Candida albicans was the most frequently detected (76.8 %). Also, species intrinsically resistant to azoles were frequently isolated (15.8 and 17.7 % of isolates and patients). (I) Infections only caused by C. albicans were significantly associated with the use of inhalation steroids (p = 0.001) and antibiotics (p = 0.04), super-infection of lichen planus (p = 0.002), and the absence of removable dentures (p < 0.001). (II) Anti-mycotics were significantly more frequently administered in patients using inhalation steroids (p = 0.001), suffering from asthma/COPD, or smoking heavily (p = 0.003) and if C. albicans and non-albicans species were detected together (p = 0.001). (III) Pathogen composition did not change over time within the examined period (p = 0.239).
Conclusions
Different variables enhance the presence of certain Candida and the antifungal prescription frequency. No species shift was evident.
Clinical relevance
The major pathogen in oral candidiasis remains C. albicans. Nevertheless, therapeutic problems may be caused by the frequent presence of species intrinsically resistant to azoles, especially in patients wearing dentures.
Similar content being viewed by others
References
Coronado-Castellote L, Jimenez-Soriano Y (2013) Clinical and microbiological diagnosis of oral candidiasis. J Clin Exp Dent 5:e279–e286. doi:10.4317/jced.51242
Aguirre Urizar JM (2002) Oral candidiasis. Revista Iberoamericana de Micologia 19:17–21
Sahand IH, Maza JL, Eraso E, Montejo M, Moragues MD, Aguirre JM, Quindos G, Ponton J (2009) Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity. J Med Microbiol 58:1437–1442. doi:10.1099/jmm.0.011320-0
Goregen M, Miloglu O, Buyukkurt MC, Caglayan F, Aktas AE (2011) Median rhomboid glossitis: a clinical and microbiological study. European Journal of Dentistry 5:367–372
Wright PS, Clark P, Hardie JM (1985) The prevalence and significance of yeasts in persons wearing complete dentures with soft-lining materials. J Dent Res 64:122–125
Shipman B (1979) Clinical evaluation of oral Candida in cancer chemotherapy patients. J Prosthet Dent 41:63–67
Odds FC (1988) Candida and candidosis: a review and bibliography. Baillière Tindall, London
Singh A, Verma R, Murari A, Agrawal A (2014) Oral candidiasis: an overview. J Oral Maxillofac Pathol 18:S81–S85. doi:10.4103/0973-029X.141325
Soysa NS, Samaranayake LP, Ellepola AN (2006) Diabetes mellitus as a contributory factor in oral candidosis. Diabet Med 23:455–459. doi:10.1111/j.1464-5491.2005.01701.x
Bensadoun R-J, Patton LL, Lalla RV, Epstein JB (2011) Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 19:737–744
Davies AN, Brailsford SR, Beighton D, Shorthose K, Stevens VC (2008) Oral candidosis in community-based patients with advanced cancer. J Pain Symptom Manag 35:508–514. doi:10.1016/j.jpainsymman.2007.07.005
Delgado AC, de Jesus PR, Aoki FH, Resende MR, Trabasso P, Colombo AL, de Oliveira MS, Mikami Y, Moretti ML (2009) Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 15:364–371
Lopez-Pintor RM, Hernandez G, de Arriba L, de Andres A (2013) Oral candidiasis in patients with renal transplants. Medicina Oral, Patologia Oral y Cirugia Bucal 18:e381–e387
Fernandez-Feijoo J, Diz-Dios P, Otero-Cepeda XL, Limeres-Posse J, de la Fuente-Aguado J and Ocampo-Hermida A (2005) Predictive value of oral candidiasis as a marker of progression to AIDS. Medicina oral, patologia oral y cirugia bucal 10:36–40; 32–6.
Gonzalez Gravina H, Gonzalez de Moran E, Zambrano O, Lozano Chourio M, Rodriguez de Valero S, Robertis S, Mesa L (2007) Oral candidiasis in children and adolescents with cancer. Identification of Candida spp. Medicina Oral, Patologia Oral y Cirugia Bucal 12:E419–E423
Rodrigues JA, Hofling JF, Tavares FC, Duarte KM, Goncalves RB, Azevedo RA (2004) Evaluation of biochemical and serological methods to identify and clustering yeast cells of oral Candida species by CHROMagar test, SDS-PAGE and ELISA. Braz J Biol 64:317–326
Gaitan Cepeda LA, Ceballos Salobrena A, Lopez Ortega K, Arzate Mora N, Jimenez Soriano Y (2008) Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence. Medicina Oral, patologia Oral y Cirugia Bucal 13:E85–E93
Soysa NS, Ellepola AN (2005) The impact of cigarette/tobacco smoking on oral candidosis: an overview. Oral Dis 11:268–273. doi:10.1111/j.1601-0825.2005.01115.x
Margaix-Munoz M, Bagan JV, Poveda R, Jimenez Y, Sarrion G (2009) Sjogren’s syndrome of the oral cavity. Review and update. Medicina Oral, Patologia Oral y Cirugia Bucal 14:E325–E330
Ergun S, Cekici A, Topcuoglu N, Migliari DA, Kulekci G, Tanyeri H, Isik G (2010) Oral status and Candida colonization in patients with Sjogren’s syndrome. Medicina Oral, Patologia Oral y Cirugia Bucal 15:e310–e315
Maver-Biscanin M, Mravak-Stipetic M, Jerolimov V (2005) Effect of low-level laser therapy on Candida albicans growth in patients with denture stomatitis. Photomed Laser Surg 23:328–332. doi:10.1089/pho.2005.23.328
Perezous LF, Stevenson GC, Flaitz CM, Goldschmidt ME, Engelmeier RL, Nichols CM (2006) The effect of complete dentures with a metal palate on candida species growth in HIV-infected patients. J Prosthodont 15:306–315. doi:10.1111/j.1532-849X.2006.00127.x
Coco BJ, Bagg J, Cross LJ, Jose A, Cross J, Ramage G (2008) Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis. Oral Microbiol Immunol 23:377–383. doi:10.1111/j.1399-302X.2008.00439.x
Uludamar A, Ozkan YK, Kadir T, Ceyhan I (2010) In vivo efficacy of alkaline peroxide tablets and mouthwashes on Candida albicans in patients with denture stomatitis. Journal of Applied oral Science : Revista FOB 18:291–296
Lal S, Chussid S (2005) Oral candidiasis in pediatric HIV patients. N Y State Dent J 71:28–31
Farah CS, Lynch N, McCullough MJ (2010) Oral fungal infections: an update for the general practitioner. Aust Dent J 55(Suppl 1):48–54. doi:10.1111/j.1834-7819.2010.01198.x
Willis AM, Coulter WA, Sullivan DJ, Coleman DC, Hayes JR, Bell PM, Lamey PJ (2000) Isolation of C. dubliniensis from insulin-using diabetes mellitus patients. Journal of Oral pathology & Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 29:86–90
Hill LV, Tan MH, Pereira LH, Embil JA (1989) Association of oral candidiasis with diabetic control. J Clin Pathol 42:502–505
Darwazeh AM, Lamey PJ, Samaranayake LP, MacFarlane TW, Fisher BM, Macrury SM, MacCuish AC (1990) The relationship between colonisation, secretor status and in-vitro adhesion of Candida albicans to buccal epithelial cells from diabetics. J Med Microbiol 33:43–49
Tekeli A, Dolapci I, Emral R, Cesur S (2004) Candida carriage and Candida dubliniensis in oropharyngeal samples of type-1 diabetes mellitus patients. Mycoses 47:315–318. doi:10.1111/j.1439-0507.2004.00996.x
Colombo A, Da Matta D, De Almeida L, Rosas R (2002) Fluconazole susceptibility of Brazilian Candida isolates assessed by disk diffusion method. Braz J Infect Dis 6:118–123
Sant’Ana PD, Milan EP, Martinez R, Queiroz-Telles F, Ferreira MS, Alcantara AP, Carvalho MT, Colombo AL (2002) Multicenter Brazilian study of oral Candida species isolated from AIDS patients. Memorias Do Instituto Oswaldo Cruz 97:253–257
Rautemaa R, Richardson M, Pfaller M, Perheentupa J, Saxen H (2008) Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole. Scand J Infect Dis 40:904–907. doi:10.1080/00365540802275853
Clark TA, Hajjeh RA (2002) Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 15:569–574. doi:10.1097/01.qco.0000044774.05458.c6
Hobson R (2003) The global epidemiology of invasive Candida infections—is the tide turning? J Hosp Infect 55:159–168
Knoke M, Schulz K, Bernhardt H (1997) Dynamics of Candida isolations from humans from 1992-1995 in Greifswald, Germany. Mycoses 40:105–110
Jham BC, Franca EC, Oliveira RR, Santos VR, Kowalski LP, Freire ARD (2007) Candida oral colonization and infection in Brazilian patients undergoing head and neck radiotherapy: a pilot study. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology 103:355–358
Mulu A, Kassu A, Anagaw B, Moges B, Gelaw A, Alemayehu M, Belyhun Y, Biadglegne F, Hurissa Z, Moges F, Isogai E (2013) Frequent detection of ‘azole’ resistant Candida species among late presenting AIDS patients in northwest Ethiopia. BMC Infect Dis 13:82. doi:10.1186/1471-2334-13-82
Niimi M, Firth NA, Cannon RD (2010) Antifungal drug resistance of oral fungi. Odontology/the Society of the Nippon Dental University 98:15–25. doi:10.1007/s10266-009-0118-3
Schmidt-Westhausen AM, Bendick C, Reichart PA, Samaranayake LP (2004) Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics. Mycoses 47:435–441
Goldman M, Cloud GA, Smedema M, LeMonte A, Connolly P, McKinsey DS, Kauffman CA, Moskovitz B, Wheat LJ, Myco NIAID (2000) Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? Antimicrob Agents Chemother 44:1585–1587
Richardson MD (2005) Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 56:5–11
Sardi J, Almeida A, Mendes Giannini M (2011) New antimicrobial therapies used against fungi present in subgingival sires—a brief review. Arch Oral Biol 56:951–959
Brusca MI, Verdugo F, Amighini C, Albaina O, Moragues MD (2014) Anabolic steroids affect human periodontal health and microbiota. Clin Oral Investig 18:1579–1586. doi:10.1007/s00784-013-1126-9
Pye A, Lockhart D, Dawson M, Murray C, Smith AJ (2009) A review of dental implants and infection. J Hosp Infect 72:104–110
Kragelund C, Kieffer-Kristensen L, Reibel J, Bennett EP (2013) Oral candidosis in lichen planus: the diagnostic approach is of major therapeutic importance. Clin Oral Investig 17:957–965. doi:10.1007/s00784-012-0757-6
Abdulrahim MH, McManus BA, Flint SR, Coleman DC (2013) Genotyping Candida albicans from Candida leukoplakia and non-Candida leukoplakia shows no enrichment of multilocus sequence typing clades but enrichment of ABC genotype C in Candida leukoplakia. PLoS One 8:e73738. doi:10.1371/journal.pone.0073738
Dahlen G (2006) Microbiological diagnostics in oral diseases. Acta Odontol Scand 64:164–168. doi:10.1080/00016350500520318
Acknowledgments
The authors thank Dr. Konrad Neumann (Charité Centre 4, Institute of Medical Biometrics and Clinical Epidemiology, Charité Medical University, Berlin, Germany) for his most valuable support in performing statistical analysis.
Excerpts of the manuscript at hand were part of an oral presentation on the annual Meeting of the Association of Maxillofacial Surgery in Bad Homburg, Germany, on May 9th, 2013. With that exception, there is no overlap between the submission and any material, published or submitted.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
ᅟ
This article does not contain any studies with human participants or animals performed by any of the authors. All procedures retrospectively using data from humans were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Formal approval was granted by the institutional ethical review committee of the Charité Universitätsmedizin Berlin (EA4/108/14). Data collected were pseudonymized at the stage of extraction from the patient’s charts. Only data assessed at our department within the regular treatment and diagnostic protocols were used.
Funding
The authors state that there are no funders to report.
Conflict of interest
All authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Hertel, M., Schmidt-Westhausen, A.M. & Strietzel, FP. Local, systemic, demographic, and health-related factors influencing pathogenic yeast spectrum and antifungal drug administration frequency in oral candidiasis: a retrospective study. Clin Oral Invest 20, 1477–1486 (2016). https://doi.org/10.1007/s00784-015-1631-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-015-1631-0